VIGABATRIN

VIGABATRIN was reported 14770 times

VIGABATRIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 INTRAMYELINIC OEDEMA 11 0.7333
1 ENLARGED FOETAL CISTERNA MAGNA 3 0.6000
2 TALIPES CORRECTION 4 0.5714
3 RETINAL FUNCTION TEST ABNORMAL 5 0.4545
4 INFANTILE SPASMS 311 0.4302
5 RETINOGRAM ABNORMAL 114 0.4254
6 EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY WITH BURST-SUPPRESSION 5 0.4167
7 CORTICAL VISUAL IMPAIRMENT 19 0.3276
8 MAGNETIC RESONANCE IMAGING HEAD ABNORMAL 202 0.3112
9 DRUG WITHDRAWAL CONVULSIONS 482 0.2708
10 KETOGENIC DIET 4 0.2222
11 BENIGN CARDIAC NEOPLASM 7 0.2121
12 INFANTILE SPITTING UP 83 0.1587
13 LISSENCEPHALY 7 0.1522
14 DIFFUSION-WEIGHTED BRAIN MRI ABNORMAL 4 0.1481
15 EPILEPTIC ENCEPHALOPATHY 30 0.1345
16 POLYNEUROPATHY IDIOPATHIC PROGRESSIVE 8 0.1194
17 OPHTHALMOLOGICAL EXAMINATION ABNORMAL 21 0.1186
18 LENNOX-GASTAUT SYNDROME 26 0.1145
19 COMA BLISTER 10 0.1111
20 TUBEROUS SCLEROSIS COMPLEX 11 0.1048
21 INVOLUNTARY VOCALISATION 3 0.1034
22 MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL 17 0.0939
23 GLYCOGEN STORAGE DISORDER 3 0.0857
24 ABDOMINAL WALL CYST 10 0.0820
25 MILD MENTAL RETARDATION 3 0.0769
26 INFANT IRRITABILITY 7 0.0714
27 ELECTROENCEPHALOGRAM 4 0.0714
28 BASILAR MIGRAINE 4 0.0635
29 CHANGE IN SEIZURE PRESENTATION 41 0.0634
30 ASTROCYTOMA, LOW GRADE 10 0.0588
31 MULTIPLE-DRUG RESISTANCE 180 0.0580
32 TRACHEOSTOMY INFECTION 7 0.0574
33 MITOCHONDRIAL ENCEPHALOMYOPATHY 4 0.0563
34 SEIZURE CLUSTER 45 0.0543
35 INABILITY TO CRAWL 3 0.0517
36 BRAIN LOBECTOMY 3 0.0508
37 CORTICAL DYSPLASIA 3 0.0508
38 CEREBRAL DYSGENESIS 3 0.0500
39 POSTICTAL PARALYSIS 12 0.0496
40 BACTERIAL TRACHEITIS 4 0.0494
41 SUDDEN UNEXPLAINED DEATH IN EPILEPSY 26 0.0486
42 TONIC CONVULSION 64 0.0451
43 ATONIC SEIZURES 36 0.0419
44 ANTICONVULSANT DRUG LEVEL ABOVE THERAPEUTIC 27 0.0415
45 EPIDURAL LIPOMATOSIS 14 0.0407
46 FOETAL VALPROATE SYNDROME 4 0.0400
47 NEONATAL BEHAVIOURAL SYNDROME 12 0.0392
48 BODY DYSMORPHIC DISORDER 14 0.0373
49 DEVELOPMENTAL REGRESSION 5 0.0368
50 GINGIVAL ATROPHY 7 0.0357
51 HYPERINTENSITY IN BRAIN DEEP NUCLEI 3 0.0357
52 BRAIN OPERATION 79 0.0346
53 OPTIC ATROPHY 53 0.0325
54 MYOCLONIC EPILEPSY 49 0.0323
55 LEUKODYSTROPHY 3 0.0323
56 TEMPORAL LOBE EPILEPSY 13 0.0297
57 RETINAL DYSTROPHY 7 0.0294
58 ENTEROVIRUS INFECTION 25 0.0289
59 FUNDOSCOPY ABNORMAL 3 0.0288
60 FEEDING INTOLERANCE 13 0.0288
61 PLAGIOCEPHALY 14 0.0281
62 VESICOURETERIC REFLUX 11 0.0272
63 FACIAL DYSMORPHISM 6 0.0271
64 NEUROSURGERY 5 0.0270
65 THERAPEUTIC PRODUCT EFFECTIVE FOR UNAPPROVED INDICATION 10 0.0270
66 FOCAL DYSCOGNITIVE SEIZURES 30 0.0263
67 RETINAL TOXICITY 27 0.0262
68 ABSENCE OF IMMEDIATE TREATMENT RESPONSE 6 0.0253
69 INFANTILE VOMITING 5 0.0253
70 ANAL ATRESIA 13 0.0243
71 NEONATAL SEIZURE 6 0.0241
72 ADENOTONSILLECTOMY 6 0.0240
73 FEBRILE CONVULSION 29 0.0238
74 STATUS EPILEPTICUS 268 0.0237
75 MAGNETIC RESONANCE IMAGING ABNORMAL 28 0.0234
76 CARNITINE DEFICIENCY 4 0.0234
77 BONE METABOLISM DISORDER 7 0.0233
78 SEIZURE 2669 0.0231
79 INTELLECTUAL DISABILITY 35 0.0230
80 RHINOVIRUS INFECTION 87 0.0223
81 EXCESSIVE EYE BLINKING 33 0.0223
82 GAZE PALSY 38 0.0223
83 RETINAL DISORDER 58 0.0223
84 SHUNT MALFUNCTION 6 0.0212
85 TRACHEITIS 16 0.0210
86 RELAPSING FEVER 6 0.0208
87 TRACHEO-OESOPHAGEAL FISTULA 13 0.0203
88 TRACHEOMALACIA 8 0.0203
89 NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL 29 0.0199
90 THERAPEUTIC PRODUCT INEFFECTIVE FOR UNAPPROVED INDICATION 9 0.0199
91 VISUAL FIELD DEFECT 142 0.0196
92 LOW SET EARS 8 0.0195
93 RETINAL INJURY 15 0.0194
94 CHOREOATHETOSIS 13 0.0191
95 AUTOMATISM 4 0.0185
96 DYSMETRIA 11 0.0182
97 COMPLEX PARTIAL SEIZURES 20 0.0180
98 PARTIAL SEIZURES 94 0.0179
99 POOR SUCKING REFLEX 7 0.0176
100 PYROGLUTAMIC ACIDOSIS 7 0.0176
101 PARTIAL SEIZURES WITH SECONDARY GENERALISATION 8 0.0171
102 BLINDNESS CORTICAL 8 0.0163
103 BULIMIA NERVOSA 7 0.0159
104 NEUROTRANSMITTER LEVEL ALTERED 3 0.0159
105 HAND-FOOT-AND-MOUTH DISEASE 13 0.0157
106 PYLORIC STENOSIS 13 0.0153
107 RESPIRATORY SYNCYTIAL VIRUS BRONCHIOLITIS 12 0.0153
108 BODY MASS INDEX DECREASED 7 0.0151
109 GASTROSTOMY TUBE SITE COMPLICATION 3 0.0150
110 PRODUCT CONTAMINATION 53 0.0149
111 MICROPHTHALMOS 4 0.0147
112 HEAD BANGING 8 0.0140
113 CLONIC CONVULSION 10 0.0137
114 ELECTROENCEPHALOGRAM ABNORMAL 43 0.0136
115 RETINAL DEPIGMENTATION 4 0.0131
116 ADENOIDECTOMY 5 0.0129
117 MUSCLE TONE DISORDER 4 0.0128
118 BRONCHIOLITIS 45 0.0128
119 CROUP INFECTIOUS 10 0.0127
120 HYPOTONIA 119 0.0119
121 STRABISMUS 35 0.0119
122 AMBLYOPIA 7 0.0118
123 CLEFT LIP AND PALATE 13 0.0116
124 GASTROSTOMY 18 0.0116
125 RETINAL DEGENERATION 15 0.0115
126 GASTROINTESTINAL VIRAL INFECTION 12 0.0115
127 CERVICOBRACHIAL SYNDROME 7 0.0114
128 OPEN ANGLE GLAUCOMA 7 0.0114
129 ASTERIXIS 12 0.0113
130 HEMIANOPIA HOMONYMOUS 8 0.0109
131 BRAIN SCAN ABNORMAL 6 0.0108
132 RESPIRATORY SYNCYTIAL VIRUS INFECTION 93 0.0107
133 CHOREA 18 0.0104
134 AVERSION 3 0.0104
135 STARING 25 0.0103
136 OPISTHOTONUS 8 0.0101
137 EPILEPSY 306 0.0100
138 DEPENDENCE ON RESPIRATOR 4 0.0100
139 DERMATITIS DIAPER 7 0.0099
140 SIMPLE PARTIAL SEIZURES 8 0.0099
141 ANTICONVULSANT DRUG LEVEL DECREASED 14 0.0099
142 RESPIRATORY TRACT INFECTION VIRAL 22 0.0094
143 CONGENITAL NOSE MALFORMATION 5 0.0094
144 HYPERCHLORAEMIA 6 0.0094
145 MULTIPLE DRUG THERAPY 7 0.0093
146 EYE MOVEMENT DISORDER 63 0.0092
147 SELF-DESTRUCTIVE BEHAVIOUR 8 0.0092
148 HAEMANGIOMA 21 0.0091
149 OCULAR TOXICITY 10 0.0091
150 LARYNGOMALACIA 3 0.0090
151 PRECOCIOUS PUBERTY 5 0.0088
152 WHITE MATTER LESION 11 0.0087
153 HYPOSPADIAS 18 0.0086
154 INCREASED BRONCHIAL SECRETION 22 0.0086
155 PARAINFLUENZAE VIRUS INFECTION 13 0.0085
156 BRAIN MALFORMATION 3 0.0084
157 FOREIGN BODY ASPIRATION 6 0.0083
158 POSTURE ABNORMAL 27 0.0083
159 PETIT MAL EPILEPSY 42 0.0082
160 OPTIC NERVE DISORDER 13 0.0081
161 ADENOIDAL HYPERTROPHY 3 0.0079
162 BREATH HOLDING 3 0.0078
163 CEREBRAL VENTRICLE DILATATION 9 0.0078
164 INTENTIONAL UNDERDOSE 56 0.0077
165 METAPNEUMOVIRUS INFECTION 6 0.0077
166 DROPPED HEAD SYNDROME 3 0.0076
167 PNEUMONIA MYCOPLASMAL 6 0.0075
168 HYDROCELE 8 0.0075
169 ANTICONVULSANT DRUG LEVEL INCREASED 12 0.0074
170 ANHIDROSIS 3 0.0074
171 GENERALISED TONIC-CLONIC SEIZURE 119 0.0072
172 APNOEIC ATTACK 4 0.0071
173 CORONA VIRUS INFECTION 3 0.0070
174 ROTAVIRUS INFECTION 4 0.0069
175 MENTAL DISABILITY 4 0.0069
176 ASPIRATION 74 0.0067
177 AMINO ACID LEVEL INCREASED 5 0.0067
178 UPPER RESPIRATORY TRACT INFLAMMATION 8 0.0067
179 MENINGOMYELOCELE 4 0.0067
180 ASTIGMATISM 10 0.0066
181 DRUG RESISTANCE 168 0.0065
182 NEURODEGENERATIVE DISORDER 4 0.0065
183 EATING DISORDER SYMPTOM 3 0.0065
184 PERIPHERAL SENSORIMOTOR NEUROPATHY 8 0.0064
185 STEREOTYPY 6 0.0064
186 RETINAL PIGMENTATION 5 0.0063
187 CEREBRAL PALSY 6 0.0063
188 HYPERMETROPIA 6 0.0063
189 INAPPROPRIATE AFFECT 10 0.0063
190 PNEUMONIA NECROTISING 4 0.0062
191 HYPOVENTILATION 20 0.0061
192 HYPERKINESIA 13 0.0061
193 DRUG DOSE OMISSION 990 0.0060
194 SCREAMING 38 0.0060
195 NEURODEVELOPMENTAL DISORDER 4 0.0059
196 AMMONIA INCREASED 30 0.0059
197 TONGUE MOVEMENT DISTURBANCE 5 0.0058
198 HEAD TITUBATION 8 0.0058
199 POSTICTAL STATE 6 0.0058
200 OTITIS MEDIA 19 0.0057
201 MITRAL VALVE DISEASE 10 0.0056
202 PNEUMONIA VIRAL 18 0.0056
203 BITE 4 0.0055
204 MANUFACTURING PRODUCT SHIPPING ISSUE 3 0.0055
205 DROOLING 38 0.0055
206 PNEUMONIA ASPIRATION 137 0.0055
207 CEREBRAL DISORDER 40 0.0054
208 TONSILLECTOMY 9 0.0054
209 LIFE SUPPORT 3 0.0053
210 ANTICONVULSANT DRUG LEVEL BELOW THERAPEUTIC 4 0.0053
211 POOR QUALITY PRODUCT ADMINISTERED 55 0.0052
212 GASTROINTESTINAL TUBE INSERTION 13 0.0052
213 RESPIRATORY DISTRESS 143 0.0052
214 RESPIRATORY DISORDER 150 0.0050
215 REFLUX GASTRITIS 6 0.0050
216 BRONCHOPULMONARY DYSPLASIA 4 0.0050
217 CHRONIC RESPIRATORY FAILURE 6 0.0050
218 PSYCHOMOTOR SKILLS IMPAIRED 13 0.0050
219 HYDROCEPHALUS 27 0.0050
220 INCORRECT DRUG DOSAGE FORM ADMINISTERED 3 0.0049
221 PRESCRIBED OVERDOSE 95 0.0049
222 TRACHEOSTOMY 7 0.0049
223 IRRITABILITY 293 0.0049
224 GRAND MAL CONVULSION 44 0.0048
225 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 4 0.0047
226 RECALLED PRODUCT ADMINISTERED 45 0.0047
227 NYSTAGMUS 25 0.0047
228 CONVULSION 267 0.0047
229 EMERGENCY CARE 14 0.0046
230 FOOD REFUSAL 4 0.0046
231 DEVELOPMENTAL DELAY 41 0.0045
232 MACROCYTOSIS 5 0.0043
233 PSYCHOGENIC SEIZURE 4 0.0043
234 CEREBRAL ATROPHY 17 0.0043
235 BEHAVIOUR DISORDER 23 0.0042
236 DYSMORPHISM 10 0.0042
237 NEPHROCALCINOSIS 5 0.0042
238 FOETAL ANTICONVULSANT SYNDROME 5 0.0042
239 EAR INFECTION 112 0.0042
240 CONGENITAL HYDRONEPHROSIS 3 0.0042
241 PERSONALITY DISORDER 11 0.0042
242 SPEECH DISORDER DEVELOPMENTAL 12 0.0042
243 CARDIAC SEPTAL DEFECT 3 0.0042
244 NASAL INJURY 3 0.0042
245 NOROVIRUS INFECTION 6 0.0042
246 LARYNGEAL DISORDER 3 0.0042
247 ALANINE AMINOTRANSFERASE DECREASED 3 0.0041
248 TOXIC ENCEPHALOPATHY 20 0.0039
249 INCREASED VISCOSITY OF UPPER RESPIRATORY SECRETION 3 0.0039
250 PLEURAL FIBROSIS 4 0.0039
251 PSYCHOMOTOR RETARDATION 11 0.0039
252 HYPOTONIA NEONATAL 6 0.0038
253 FEEDING DISORDER NEONATAL 4 0.0038
254 ABNORMAL BEHAVIOUR 149 0.0038
255 TUNNEL VISION 7 0.0037
256 LEARNING DISORDER 9 0.0037
257 SALIVARY HYPERSECRETION 36 0.0036
258 FACIAL SPASM 4 0.0036
259 ENCEPHALOPATHY 87 0.0035
260 PRODUCT PREPARATION ERROR 72 0.0035
261 CRYING 127 0.0035
262 REGURGITATION 12 0.0035
263 INCORRECT DOSAGE ADMINISTERED 17 0.0035
264 ADENOVIRUS INFECTION 10 0.0034
265 SPINA BIFIDA 7 0.0034
266 GINGIVAL HYPERTROPHY 5 0.0033
267 DRUG DOSE TITRATION NOT PERFORMED 6 0.0033
268 OTITIS EXTERNA 4 0.0033
269 GASTRIC OPERATION 3 0.0033
270 AGGRESSION 163 0.0033
271 VIRAL INFECTION 108 0.0032
272 ACUTE RESPIRATORY FAILURE 62 0.0032
273 ATAXIA 38 0.0032
274 NEUROTOXICITY 55 0.0031
275 APNOEA 24 0.0031
276 TONIC CLONIC MOVEMENTS 4 0.0031
277 STRIDOR 9 0.0031
278 LISTLESS 10 0.0030
279 PSYCHOMOTOR HYPERACTIVITY 50 0.0030
280 SOMNOLENCE 603 0.0030
281 SEIZURE LIKE PHENOMENA 5 0.0029
282 FAILURE TO THRIVE 15 0.0029
283 HYPOPNOEA 10 0.0029
284 HEART DISEASE CONGENITAL 10 0.0028
285 PRODUCT SUPPLY ISSUE 20 0.0028
286 INTRACRANIAL VENOUS SINUS THROMBOSIS 3 0.0028
287 ADVERSE EVENT 257 0.0028
288 SEDATION 73 0.0028
289 CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY 3 0.0028
290 GASTROENTERITIS VIRAL 50 0.0028
291 PRODUCT PREPARATION ISSUE 18 0.0027
292 NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL 9 0.0027
293 HYPERTHERMIA MALIGNANT 4 0.0027
294 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 7 0.0027
295 HYDRONEPHROSIS 20 0.0027
296 HYPERCAPNIA 8 0.0027
297 HYPERTONIA 15 0.0026
298 FOLATE DEFICIENCY 3 0.0026
299 BRADYPNOEA 7 0.0026
300 CLUMSINESS 7 0.0026
301 CLONUS 7 0.0026
302 HYPORESPONSIVE TO STIMULI 3 0.0026
303 LETHARGY 147 0.0026
304 VIRAL UPPER RESPIRATORY TRACT INFECTION 12 0.0025
305 MYOCLONUS 30 0.0025
306 RESPIRATORY TRACT INFECTION 65 0.0025
307 DIABETES INSIPIDUS 6 0.0025
308 HOSPITALISATION 374 0.0024
309 PARAPLEGIA 7 0.0024
310 QUADRIPARESIS 4 0.0024
311 BRAIN NEOPLASM 22 0.0024
312 DYSKINESIA 97 0.0024
313 HYPERSOMNIA 68 0.0024
314 OPTIC NEUROPATHY 5 0.0024
315 FEELING OF DESPAIR 11 0.0024
316 COMMUNICATION DISORDER 9 0.0024
317 PHYSICAL DECONDITIONING 6 0.0023
318 DRUG TITRATION ERROR 6 0.0023
319 LANGUAGE DISORDER 5 0.0023
320 HYPOPITUITARISM 4 0.0023
321 HIRSUTISM 3 0.0023
322 RESPIRATORY FAILURE 164 0.0022
323 CALCULUS BLADDER 3 0.0022
324 AUTISM SPECTRUM DISORDER 12 0.0022
325 DRUG LEVEL DECREASED 22 0.0022
326 AURA 4 0.0021
327 INCREASED UPPER AIRWAY SECRETION 11 0.0021
328 RESPIRATORY RATE INCREASED 19 0.0021
329 LIP DISORDER 4 0.0021
330 MULTIPLE CONGENITAL ABNORMALITIES 3 0.0021
331 GINGIVAL DISORDER 8 0.0021
332 CLEFT PALATE 4 0.0021
333 PNEUMONIA BACTERIAL 19 0.0021
334 HYPOTHALAMO-PITUITARY DISORDER 3 0.0021
335 PRODUCT ADMINISTRATION INTERRUPTED 16 0.0020
336 GENE MUTATION 4 0.0020
337 HYPERAMMONAEMIA 10 0.0020
338 MUSCLE TWITCHING 46 0.0020
339 SLEEP TERROR 8 0.0019
340 RESPIRATION ABNORMAL 13 0.0019
341 RENAL NEOPLASM 4 0.0019
342 HYPOVOLAEMIC SHOCK 9 0.0019
343 CUSHINGOID 6 0.0019
344 SYMPTOM RECURRENCE 11 0.0018
345 DRUG LEVEL INCREASED 30 0.0018
346 HYPERNATRAEMIA 9 0.0018
347 LINEAR IGA DISEASE 3 0.0018
348 THERAPY PARTIAL RESPONDER 28 0.0018
349 CYANOSIS 28 0.0018
350 HYPOTHERMIA 18 0.0018
351 OXYGEN SATURATION ABNORMAL 5 0.0018
352 THERAPY NON-RESPONDER 79 0.0018
353 DISEASE COMPLICATION 8 0.0017
354 BLEPHAROSPASM 11 0.0017
355 EYE OPERATION 8 0.0017
356 HYPERAMMONAEMIC ENCEPHALOPATHY 3 0.0017
357 AUTONOMIC NERVOUS SYSTEM IMBALANCE 5 0.0017
358 WRONG PATIENT RECEIVED PRODUCT 5 0.0017
359 PNEUMONIA 549 0.0017
360 MACULOPATHY 6 0.0017
361 BRUXISM 9 0.0017
362 WEIGHT ABNORMAL 4 0.0017
363 MOOD ALTERED 45 0.0016
364 UPPER RESPIRATORY TRACT INFECTION 76 0.0016
365 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 10 0.0016
366 RENAL CYST 13 0.0016
367 RESPIRATORY ARREST 45 0.0016
368 METAMORPHOPSIA 3 0.0016
369 THERAPY CHANGE 16 0.0016
370 TALIPES 5 0.0016
371 JOINT DISLOCATION 17 0.0016
372 ACUTE PULMONARY OEDEMA 9 0.0016
373 URINE OUTPUT DECREASED 14 0.0016
374 WRONG TECHNIQUE IN DRUG USAGE PROCESS 58 0.0016
375 BLINDNESS 65 0.0016
376 PRODUCT DOSE OMISSION 104 0.0016
377 FACE INJURY 6 0.0016
378 HYPOREFLEXIA 3 0.0016
379 AGITATION 114 0.0016
380 APATHY 22 0.0015
381 BRAIN INJURY 15 0.0015
382 DYSTONIA 29 0.0015
383 POTENTIATING DRUG INTERACTION 5 0.0015
384 FOAMING AT MOUTH 3 0.0015
385 JAW DISORDER 8 0.0015
386 BRONCHOPNEUMONIA 5 0.0015
387 DRUG LEVEL BELOW THERAPEUTIC 8 0.0014
388 SURGERY 85 0.0014
389 MICROCYTIC ANAEMIA 3 0.0014
390 ENDOTRACHEAL INTUBATION 4 0.0014
391 VISUAL IMPAIRMENT 176 0.0014
392 ANAEMIA MACROCYTIC 3 0.0014
393 PRODUCT DISPENSING ISSUE 6 0.0014
394 POOR QUALITY SLEEP 30 0.0014
395 FACIAL PALSY 3 0.0014
396 OXYGEN SATURATION DECREASED 78 0.0014
397 CHOKING 27 0.0014
398 FEEDING DISORDER 28 0.0014
399 TOOTH DISCOLOURATION 4 0.0014
400 RETINOPATHY 5 0.0013
401 ANGER 45 0.0013
402 HYPOPHAGIA 34 0.0013
403 PNEUMOTHORAX 21 0.0013
404 UNRESPONSIVE TO STIMULI 34 0.0013
405 BUNDLE BRANCH BLOCK RIGHT 6 0.0013
406 MASTICATION DISORDER 4 0.0013
407 MATERNAL DRUGS AFFECTING FOETUS 10 0.0013
408 EYELID DISORDER 3 0.0013
409 NEUROLOGICAL DECOMPENSATION 3 0.0013
410 HIP SURGERY 7 0.0013
411 APHTHOUS ULCER 10 0.0013
412 ADVERSE REACTION 17 0.0013
413 PRODUCT DOSE OMISSION ISSUE 376 0.0013
414 SECRETION DISCHARGE 16 0.0013
415 MOVEMENT DISORDER 41 0.0013
416 RESPIRATORY RATE DECREASED 4 0.0013
417 MYOPIA 3 0.0013
418 MALNUTRITION 14 0.0013
419 STUPOR 4 0.0012
420 OEDEMA MOUTH 4 0.0012
421 NEOPLASM 14 0.0012
422 HYPERURICAEMIA 5 0.0012
423 FEELING DRUNK 9 0.0012
424 METABOLIC DISORDER 7 0.0012
425 URINE ODOUR ABNORMAL 7 0.0012
426 MOTOR DYSFUNCTION 12 0.0012
427 ESCHERICHIA URINARY TRACT INFECTION 5 0.0012
428 VISUAL ACUITY REDUCED 39 0.0012
429 HORDEOLUM 5 0.0012
430 HYPERREFLEXIA 4 0.0011
431 TREATMENT FAILURE 95 0.0011
432 AFFECTIVE DISORDER 9 0.0011
433 MUSCLE CONTRACTIONS INVOLUNTARY 4 0.0011
434 GINGIVAL SWELLING 5 0.0011
435 MOOD SWINGS 36 0.0011
436 NORMAL NEWBORN 6 0.0011
437 FAECES SOFT 8 0.0011
438 NONSPECIFIC REACTION 6 0.0011
439 DRUG INEFFECTIVE 1436 0.0011
440 HYPOPHOSPHATAEMIA 8 0.0011
441 STREPTOCOCCAL INFECTION 6 0.0011
442 CONJUNCTIVITIS 20 0.0011
443 BRADYCARDIA 57 0.0011
444 LUNG CONSOLIDATION 3 0.0011
445 COMA 51 0.0011
446 METABOLIC ACIDOSIS 34 0.0011
447 APPETITE DISORDER 7 0.0011
448 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 18 0.0010
449 NEUROLOGICAL SYMPTOM 6 0.0010
450 PSEUDOMONAS INFECTION 9 0.0010
451 INFLUENZA 117 0.0010
452 PROCEDURAL COMPLICATION 8 0.0010
453 APHAGIA 5 0.0010
454 FINE MOTOR SKILL DYSFUNCTION 3 0.0010
455 DEATH 891 0.0010
456 PRODUCT TASTE ABNORMAL 14 0.0010
457 CONGENITAL ANOMALY 8 0.0010
458 EATING DISORDER 22 0.0010
459 VOMITING 480 0.0010
460 ALTERED STATE OF CONSCIOUSNESS 22 0.0010
461 THERAPY CESSATION 52 0.0010
462 EYE DISORDER 33 0.0010
463 HYPERPHAGIA 4 0.0010
464 DERMATITIS EXFOLIATIVE 5 0.0010
465 SPINAL FUSION SURGERY 4 0.0010
466 PRODUCT USE ISSUE 185 0.0010
467 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 54 0.0010
468 DYSCHEZIA 3 0.0010
469 ORAL PAIN 22 0.0010
470 SLEEP DISORDER 69 0.0010
471 GOITRE 4 0.0010
472 CONDITION AGGRAVATED 297 0.0010
473 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 6 0.0010
474 ADVERSE DRUG REACTION 87 0.0010
475 DIPLOPIA 25 0.0010
476 MYOCARDITIS 11 0.0010
477 MALABSORPTION 5 0.0010
478 RESTLESSNESS 35 0.0010
479 TACHYPNOEA 13 0.0010
480 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 68 0.0010
481 BLOOD LACTIC ACID INCREASED 5 0.0009
482 HEAD INJURY 30 0.0009
483 DRUG INTERACTION 150 0.0009
484 AORTIC VALVE INCOMPETENCE 4 0.0009
485 INSOMNIA 248 0.0009
486 HAEMODYNAMIC INSTABILITY 7 0.0009
487 TIC 5 0.0009
488 MIDDLE INSOMNIA 17 0.0009
489 RETCHING 19 0.0009
490 PAPILLOEDEMA 4 0.0009
491 EYE INFECTION 10 0.0009
492 PSYCHOTIC DISORDER 26 0.0009
493 ACCIDENTAL OVERDOSE 32 0.0009
494 EAR DISORDER 4 0.0009
495 ENCEPHALITIS 6 0.0009
496 LOGORRHOEA 3 0.0009
497 NEPHROLITHIASIS 39 0.0008
498 ENERGY INCREASED 5 0.0008
499 SLEEP APNOEA SYNDROME 16 0.0008
500 URINARY TRACT INFECTION 143 0.0008
501 INCREASED APPETITE 16 0.0008
502 PULMONARY CONGESTION 11 0.0008
503 FOOD INTOLERANCE 3 0.0008
504 RESPIRATORY TRACT CONGESTION 13 0.0008
505 TREMOR 135 0.0008
506 BREATH SOUNDS ABNORMAL 4 0.0008
507 PYREXIA 280 0.0008
508 PYELONEPHRITIS 7 0.0008
509 SCOLIOSIS 5 0.0008
510 NERVOUS SYSTEM DISORDER 25 0.0008
511 PRODUCT AVAILABILITY ISSUE 18 0.0008
512 COORDINATION ABNORMAL 11 0.0008
513 NASOPHARYNGITIS 145 0.0008
514 BOWEL MOVEMENT IRREGULARITY 6 0.0008
515 INITIAL INSOMNIA 8 0.0008
516 HAEMOLYSIS 6 0.0008
517 TONSILLITIS 4 0.0008
518 WITHDRAWAL SYNDROME 32 0.0008
519 CATATONIA 4 0.0008
520 THERAPY INTERRUPTED 54 0.0008
521 PRODUCT DISTRIBUTION ISSUE 7 0.0008
522 MUSCLE RIGIDITY 9 0.0008
523 THINKING ABNORMAL 14 0.0008
524 JOINT INJURY 16 0.0007
525 DYSPHAGIA 71 0.0007
526 FUNGAL SKIN INFECTION 3 0.0007
527 BRONCHITIS 55 0.0007
528 ENURESIS 3 0.0007
529 DECREASED ACTIVITY 8 0.0007
530 PHARYNGITIS STREPTOCOCCAL 8 0.0007
531 DRUG EXPOSURE DURING PREGNANCY 25 0.0007
532 RESPIRATORY DEPRESSION 9 0.0007
533 MUSCLE SPASTICITY 9 0.0007
534 TOXICITY TO VARIOUS AGENTS 123 0.0007
535 ACCIDENTAL EXPOSURE 3 0.0007
536 MENTAL STATUS CHANGES 20 0.0007
537 INSURANCE ISSUE 11 0.0007
538 BRAIN OEDEMA 9 0.0007
539 HEART RATE DECREASED 25 0.0007
540 COGNITIVE DISORDER 33 0.0007
541 PALLOR 19 0.0007
542 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 5 0.0007
543 DISEASE RECURRENCE 33 0.0007
544 URINARY RETENTION 23 0.0007
545 DEPRESSED LEVEL OF CONSCIOUSNESS 27 0.0007
546 ORAL DISORDER 5 0.0007
547 HYPOXIA 24 0.0007
548 CARDIAC ARREST 56 0.0007
549 PRODUCT SUBSTITUTION ISSUE 39 0.0007
550 DRUG PRESCRIBING ERROR 13 0.0007
551 DRUG EFFECT LESS THAN EXPECTED 10 0.0007
552 HERNIA 13 0.0007
553 ILEUS PARALYTIC 3 0.0007
554 NASAL CONGESTION 39 0.0007
555 DECREASED APPETITE 153 0.0007
556 ACIDOSIS 5 0.0007
557 SPEECH DISORDER 34 0.0006
558 SKIN LACERATION 7 0.0006
559 BACTERIAL INFECTION 12 0.0006
560 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 130 0.0006
561 LACERATION 6 0.0006
562 MULTIPLE ALLERGIES 5 0.0006
563 INCORRECT DOSE ADMINISTERED 145 0.0006
564 MYDRIASIS 8 0.0006
565 MIOSIS 5 0.0006
566 RHINITIS 5 0.0006
567 MOUTH ULCERATION 13 0.0006
568 GASTROENTERITIS 9 0.0006
569 BLOOD POTASSIUM INCREASED 10 0.0006
570 THIRST 11 0.0006
571 HORMONE LEVEL ABNORMAL 3 0.0006
572 DEHYDRATION 82 0.0006
573 ASPHYXIA 5 0.0006
574 BODY TEMPERATURE DECREASED 6 0.0006
575 DRUG WITHDRAWAL SYNDROME NEONATAL 9 0.0006
576 ESCHERICHIA INFECTION 5 0.0006
577 ELECTROLYTE IMBALANCE 7 0.0006
578 ILLNESS 62 0.0006
579 CARDIO-RESPIRATORY ARREST 25 0.0006
580 SEPTIC SHOCK 26 0.0006
581 WRONG PRODUCT ADMINISTERED 4 0.0006
582 HAEMATEMESIS 15 0.0006
583 BLOOD SODIUM DECREASED 11 0.0006
584 MUSCLE SPASMS 107 0.0006
585 CARDIAC OPERATION 5 0.0006
586 STOMATITIS 35 0.0006
587 FORMICATION 4 0.0006
588 INFECTION 83 0.0006
589 POST PROCEDURAL COMPLICATION 11 0.0006
590 WEIGHT INCREASED 128 0.0006
591 DRUG INTOLERANCE 55 0.0006
592 SMALL INTESTINAL OBSTRUCTION 7 0.0006
593 EXTRAPYRAMIDAL DISORDER 14 0.0006
594 THERMAL BURN 4 0.0006
595 MUSCLE TIGHTNESS 9 0.0006
596 CONSTIPATION 121 0.0006
597 EMOTIONAL DISORDER 17 0.0006
598 HYPOKINESIA 8 0.0006
599 HYPONATRAEMIA 31 0.0005
600 PANCREATITIS 29 0.0005
601 FAECALOMA 3 0.0005
602 DENTAL CARIES 6 0.0005
603 IRON DEFICIENCY ANAEMIA 5 0.0005
604 PERSONALITY CHANGE 5 0.0005
605 HEART RATE ABNORMAL 3 0.0005
606 MUSCULOSKELETAL STIFFNESS 47 0.0005
607 PHOTOPHOBIA 10 0.0005
608 HEMIPARESIS 9 0.0005
609 OFF LABEL USE 465 0.0005
610 MITRAL VALVE INCOMPETENCE 6 0.0005
611 APHASIA 16 0.0005
612 MENTAL DISORDER 23 0.0005
613 RHINORRHOEA 34 0.0005
614 SEPSIS 58 0.0005
615 HYPERVENTILATION 3 0.0005
616 ATELECTASIS 5 0.0005
617 GASTROINTESTINAL DISORDER 46 0.0005
618 PARKINSONISM 5 0.0005
619 PULMONARY HAEMORRHAGE 4 0.0005
620 COLD SWEAT 9 0.0005
621 BLOOD TRIGLYCERIDES INCREASED 9 0.0005
622 ACUTE RESPIRATORY DISTRESS SYNDROME 9 0.0005
623 FRUSTRATION TOLERANCE DECREASED 4 0.0005
624 SEASONAL ALLERGY 7 0.0005
625 PHARYNGITIS 6 0.0005
626 MENSTRUAL DISORDER 4 0.0005
627 ILEUS 6 0.0005
628 UNDERDOSE 35 0.0005
629 PETECHIAE 5 0.0005
630 GASTRIC ULCER 9 0.0005
631 INCONTINENCE 5 0.0005
632 GASTROOESOPHAGEAL REFLUX DISEASE 38 0.0005
633 PARANOIA 8 0.0005
634 HYPERPROLACTINAEMIA 3 0.0005
635 BRADYPHRENIA 3 0.0005
636 CLOSTRIDIUM DIFFICILE INFECTION 10 0.0005
637 DYSGRAPHIA 3 0.0005
638 CORONAVIRUS INFECTION 3 0.0005
639 SOPOR 6 0.0005
640 GAMMA-GLUTAMYLTRANSFERASE INCREASED 10 0.0005
641 TOOTH DISORDER 10 0.0004
642 MENINGITIS 3 0.0004
643 QUALITY OF LIFE DECREASED 6 0.0004
644 FEAR 12 0.0004
645 SKIN INFECTION 5 0.0004
646 INTENTIONAL SELF-INJURY 9 0.0004
647 PRODUCT ADMINISTRATION ERROR 9 0.0004
648 DISTURBANCE IN ATTENTION 24 0.0004
649 PRODUCT USE COMPLAINT 7 0.0004
650 REBOUND EFFECT 5 0.0004
651 DRUG TOXICITY 6 0.0004
652 SCIATICA 7 0.0004
653 COUGH 123 0.0004
654 PERIPHERAL COLDNESS 6 0.0004
655 UROSEPSIS 4 0.0004
656 THERAPEUTIC RESPONSE DECREASED 26 0.0004
657 DISSEMINATED INTRAVASCULAR COAGULATION 6 0.0004
658 THERAPEUTIC PRODUCT EFFECT DECREASED 19 0.0004
659 HEART RATE INCREASED 42 0.0004
660 DRUG ADMINISTRATION ERROR 13 0.0004
661 HYPOCALCAEMIA 8 0.0004
662 DEAFNESS 11 0.0004
663 GLAUCOMA 8 0.0004
664 SINUS BRADYCARDIA 4 0.0004
665 CIRCULATORY COLLAPSE 7 0.0004
666 DYSSTASIA 12 0.0004
667 MOUTH HAEMORRHAGE 3 0.0004
668 HYPERCALCAEMIA 5 0.0004
669 CYST 5 0.0004
670 IMMUNODEFICIENCY 6 0.0004
671 ABORTION SPONTANEOUS 16 0.0004
672 POISONING 5 0.0004
673 MALAISE 173 0.0004
674 THROMBOCYTOPENIA 44 0.0004
675 HYPERTHERMIA 3 0.0004
676 SLUGGISHNESS 4 0.0004
677 SHOCK 9 0.0004
678 FALL 130 0.0004
679 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 10 0.0004
680 LUNG INFECTION 6 0.0004
681 HAEMORRHAGIC STROKE 3 0.0004
682 SWELLING FACE 25 0.0004
683 UNEVALUABLE EVENT 29 0.0004
684 WEIGHT FLUCTUATION 4 0.0004
685 PRODUCT ODOUR ABNORMAL 4 0.0004
686 INCORRECT PRODUCT STORAGE 5 0.0004
687 PRODUCT USE IN UNAPPROVED INDICATION 94 0.0004
688 SUDDEN DEATH 4 0.0004
689 BLOOD DISORDER 3 0.0004
690 BLISTER 21 0.0004
691 URINARY INCONTINENCE 11 0.0004
692 BALANCE DISORDER 32 0.0004
693 FRACTURE 7 0.0004
694 LUNG DISORDER 18 0.0004
695 CENTRAL NERVOUS SYSTEM LESION 5 0.0004
696 FOOT DEFORMITY 4 0.0004
697 HEMIPLEGIA 3 0.0004
698 COAGULOPATHY 6 0.0004
699 OBSTRUCTIVE AIRWAYS DISORDER 4 0.0004
700 LYMPHOPENIA 5 0.0004
701 GAIT DISTURBANCE 67 0.0003
702 ANURIA 3 0.0003
703 CARDIAC MURMUR 3 0.0003
704 HYPOKALAEMIA 16 0.0003
705 COMPLICATION ASSOCIATED WITH DEVICE 5 0.0003
706 CAESAREAN SECTION 4 0.0003
707 BODY TEMPERATURE INCREASED 7 0.0003
708 AMENORRHOEA 6 0.0003
709 MEDICATION ERROR 19 0.0003
710 COVID-19 PNEUMONIA 4 0.0003
711 GASTROINTESTINAL INFECTION 3 0.0003
712 ANAL INCONTINENCE 3 0.0003
713 LEUKOCYTOSIS 6 0.0003
714 GENERAL PHYSICAL HEALTH DETERIORATION 38 0.0003
715 GENERALISED OEDEMA 4 0.0003
716 HEPATIC ENCEPHALOPATHY 3 0.0003
717 DIARRHOEA HAEMORRHAGIC 3 0.0003
718 COVID-19 56 0.0003
719 MULTIPLE ORGAN DYSFUNCTION SYNDROME 9 0.0003
720 INTENTIONAL DOSE OMISSION 9 0.0003
721 BLOOD LACTATE DEHYDROGENASE INCREASED 5 0.0003
722 HYPERKALAEMIA 11 0.0003
723 BLOOD CREATINE PHOSPHOKINASE INCREASED 9 0.0003
724 RASH 136 0.0003
725 NEUTROPENIA 42 0.0003
726 MUSCULAR WEAKNESS 35 0.0003
727 PLATELET COUNT INCREASED 4 0.0003
728 NERVOUSNESS 16 0.0003
729 KIDNEY INFECTION 6 0.0003
730 DECREASED IMMUNE RESPONSIVENESS 3 0.0003
731 EXPOSURE DURING PREGNANCY 19 0.0003
732 HEPATOMEGALY 3 0.0003
733 SKIN DISCOLOURATION 14 0.0003
734 BEDRIDDEN 4 0.0003
735 GASTRITIS 8 0.0003
736 IMMUNE SYSTEM DISORDER 4 0.0003
737 LIGAMENT SPRAIN 3 0.0003
738 PHOTOSENSITIVITY REACTION 5 0.0003
739 FATIGUE 234 0.0003
740 BLOOD CHOLESTEROL INCREASED 14 0.0003
741 PRODUCT PHYSICAL ISSUE 6 0.0003
742 EPISTAXIS 22 0.0003
743 PRODUCTIVE COUGH 14 0.0003
744 GINGIVAL BLEEDING 4 0.0003
745 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 3 0.0003
746 MATERNAL EXPOSURE DURING PREGNANCY 26 0.0003
747 VISION BLURRED 40 0.0003
748 FEMUR FRACTURE 9 0.0003
749 HAEMATOCHEZIA 16 0.0003
750 LOSS OF CONSCIOUSNESS 37 0.0003
751 EYE DISCHARGE 3 0.0003
752 HUNGER 4 0.0003
753 MASS 4 0.0003
754 SKIN REACTION 4 0.0003
755 HEPATOCELLULAR INJURY 4 0.0003
756 DIALYSIS 4 0.0003
757 HYPERSENSITIVITY 52 0.0003
758 PARALYSIS 4 0.0003
759 SUBDURAL HAEMATOMA 4 0.0003
760 VERTIGO 17 0.0003
761 DISORIENTATION 11 0.0003
762 OCULAR HYPERAEMIA 13 0.0003
763 STAPHYLOCOCCAL INFECTION 9 0.0003
764 LIVER DISORDER 12 0.0003
765 STEVENS-JOHNSON SYNDROME 6 0.0003
766 GAIT INABILITY 9 0.0003
767 RASH PAPULAR 6 0.0003
768 ECZEMA 14 0.0003
769 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 19 0.0003
770 PREMATURE BABY 8 0.0003
771 DYSPNOEA 150 0.0003
772 DEPRESSED MOOD 14 0.0003
773 MUSCULOSKELETAL DISORDER 5 0.0003
774 DRUG DISPENSING ERROR 4 0.0003
775 GASTRIC HAEMORRHAGE 3 0.0003
776 DEVICE RELATED INFECTION 4 0.0003
777 CELLULITIS 13 0.0003
778 TREATMENT NONCOMPLIANCE 14 0.0003
779 WEIGHT DECREASED 71 0.0003
780 HALLUCINATION 19 0.0003
781 CYSTITIS 8 0.0003
782 INTENTIONAL PRODUCT USE ISSUE 22 0.0003
783 HYPERLIPIDAEMIA 3 0.0003
784 OVERDOSE 54 0.0003
785 PREGNANCY 5 0.0002
786 ADRENAL INSUFFICIENCY 3 0.0002
787 EXTRA DOSE ADMINISTERED 10 0.0002
788 FOETAL EXPOSURE DURING PREGNANCY 20 0.0002
789 PULMONARY OEDEMA 11 0.0002
790 DYSURIA 9 0.0002
791 ABDOMINAL DISCOMFORT 41 0.0002
792 MEMORY IMPAIRMENT 33 0.0002
793 PULMONARY HYPERTENSION 5 0.0002
794 CANDIDA INFECTION 4 0.0002
795 HALLUCINATION, VISUAL 5 0.0002
796 DISEASE PROGRESSION 28 0.0002
797 DIZZINESS 117 0.0002
798 ARRHYTHMIA 11 0.0002
799 RASH GENERALISED 6 0.0002
800 MULTI-ORGAN FAILURE 4 0.0002
801 FAECES DISCOLOURED 5 0.0002
802 FLUSHING 23 0.0002
803 DRUG DEPENDENCE 36 0.0002
804 THERAPEUTIC RESPONSE UNEXPECTED 10 0.0002
805 OEDEMA PERIPHERAL 27 0.0002
806 TOOTHACHE 4 0.0002
807 LIMB INJURY 6 0.0002
808 AKATHISIA 3 0.0002
809 PERICARDIAL EFFUSION 5 0.0002
810 AMNESIA 14 0.0002
811 RENAL DISORDER 10 0.0002
812 SUICIDE ATTEMPT 13 0.0002
813 DISCOMFORT 13 0.0002
814 TARDIVE DYSKINESIA 6 0.0002
815 PRODUCT DOSE OMISSION IN ERROR 6 0.0002
816 FLATULENCE 12 0.0002
817 COLITIS 8 0.0002
818 BLOOD URINE PRESENT 4 0.0002
819 PRODUCT PRESCRIBING ERROR 5 0.0002
820 CARDIOGENIC SHOCK 3 0.0002
821 LOWER LIMB FRACTURE 4 0.0002
822 DIARRHOEA 134 0.0002
823 MENTAL IMPAIRMENT 5 0.0002
824 EAR PAIN 4 0.0002
825 SINUSITIS 21 0.0002
826 TACHYCARDIA 18 0.0002
827 ABASIA 5 0.0002
828 UPPER LIMB FRACTURE 4 0.0002
829 BLOOD POTASSIUM DECREASED 6 0.0002
830 CARDIAC FAILURE 16 0.0002
831 NO ADVERSE EVENT 36 0.0002
832 LACRIMATION INCREASED 6 0.0002
833 LOWER RESPIRATORY TRACT INFECTION 9 0.0002
834 ACNE 15 0.0002
835 DELUSION 3 0.0002
836 DRUG-INDUCED LIVER INJURY 6 0.0002
837 MUCOSAL INFLAMMATION 5 0.0002
838 CONFUSIONAL STATE 30 0.0002
839 HYPOGLYCAEMIA 9 0.0002
840 WHEEZING 11 0.0002
841 HAEMOGLOBIN DECREASED 19 0.0002
842 PNEUMONITIS 5 0.0002
843 PRODUCT PRESCRIBING ISSUE 4 0.0002
844 MANIA 3 0.0002
845 HYPERTENSION 38 0.0002
846 HAEMOPTYSIS 5 0.0002
847 ANAEMIA 34 0.0002
848 PANCREATITIS ACUTE 4 0.0002
849 ASTHMA 20 0.0002
850 FEELING ABNORMAL 42 0.0002
851 RASH MACULAR 6 0.0002
852 OSTEOPOROSIS 7 0.0002
853 LABORATORY TEST ABNORMAL 5 0.0002
854 CATARACT 10 0.0002
855 RHABDOMYOLYSIS 7 0.0002
856 DRUG EFFECT DECREASED 9 0.0002
857 HEPATIC FAILURE 5 0.0002
858 C-REACTIVE PROTEIN INCREASED 6 0.0002
859 ILL-DEFINED DISORDER 10 0.0002
860 ANAPHYLACTIC REACTION 9 0.0002
861 ABDOMINAL DISTENSION 17 0.0002
862 HYPOACUSIS 7 0.0002
863 ASTHENIA 61 0.0002
864 EYE SWELLING 6 0.0002
865 LEUKOPENIA 8 0.0002
866 DRUG WITHDRAWAL SYNDROME 14 0.0002
867 EYE PAIN 9 0.0002
868 FOOT FRACTURE 3 0.0002
869 FEELING JITTERY 3 0.0002
870 MIGRAINE 15 0.0002
871 WHITE BLOOD CELL COUNT INCREASED 6 0.0002
872 CHOLESTASIS 3 0.0002
873 DEPRESSION 35 0.0002
874 JOINT STIFFNESS 4 0.0002
875 EXPIRED PRODUCT ADMINISTERED 5 0.0002
876 LIP SWELLING 5 0.0001
877 MENSTRUATION IRREGULAR 4 0.0001
878 JAUNDICE 4 0.0001
879 TYPE 2 DIABETES MELLITUS 5 0.0001
880 PLEURAL EFFUSION 9 0.0001
881 ANXIETY 42 0.0001
882 NEUTROPHIL COUNT DECREASED 6 0.0001
883 BLOOD GLUCOSE DECREASED 7 0.0001
884 POLLAKIURIA 6 0.0001
885 ROAD TRAFFIC ACCIDENT 6 0.0001
886 PANCYTOPENIA 8 0.0001
887 ALOPECIA 28 0.0001
888 SUICIDAL IDEATION 13 0.0001
889 PRODUCT QUALITY ISSUE 19 0.0001
890 HERPES ZOSTER 8 0.0001
891 SWELLING 13 0.0001
892 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 25 0.0001
893 URTICARIA 23 0.0001
894 PANIC ATTACK 5 0.0001
895 INTENTIONAL PRODUCT MISUSE 12 0.0001
896 RENAL FAILURE 18 0.0001
897 HYPOTENSION 27 0.0001
898 HAEMORRHAGE 14 0.0001
899 HEPATIC ENZYME INCREASED 9 0.0001
900 ERYTHEMA 27 0.0001
901 ABDOMINAL PAIN UPPER 27 0.0001
902 FEELING HOT 8 0.0001
903 INJURY 9 0.0001
904 RASH ERYTHEMATOUS 6 0.0001
905 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 6 0.0001
906 HIP FRACTURE 4 0.0001
907 HYPERHIDROSIS 16 0.0001
908 BLOOD CREATININE INCREASED 8 0.0001
909 DYSGEUSIA 9 0.0001
910 BLOOD ALKALINE PHOSPHATASE INCREASED 3 0.0001
911 EYE PRURITUS 4 0.0001
912 RENAL FAILURE ACUTE 5 0.0001
913 HEPATITIS 3 0.0001
914 GASTRIC DISORDER 4 0.0001
915 NEOPLASM PROGRESSION 4 0.0001
916 CONTUSION 11 0.0001
917 ALANINE AMINOTRANSFERASE INCREASED 7 0.0001
918 INCORRECT ROUTE OF DRUG ADMINISTRATION 4 0.0001
919 MOBILITY DECREASED 8 0.0001
920 ELECTROCARDIOGRAM QT PROLONGED 4 0.0001
921 MYELOSUPPRESSION 4 0.0001
922 BLOOD BILIRUBIN INCREASED 3 0.0001
923 CHILLS 13 0.0001
924 SYNCOPE 11 0.0001
925 INFLUENZA LIKE ILLNESS 9 0.0001
926 DYSARTHRIA 4 0.0001
927 NAUSEA 84 0.0001
928 PERIPHERAL SWELLING 16 0.0001
929 HEADACHE 65 0.0001
930 INTERSTITIAL LUNG DISEASE 5 0.0001
931 LIVER FUNCTION TEST ABNORMAL 3 0.0001
932 DYSPHONIA 6 0.0001
933 FLUID RETENTION 5 0.0001
934 OROPHARYNGEAL PAIN 9 0.0001
935 INFLAMMATION 5 0.0001
936 CARDIAC DISORDER 9 0.0001
937 ASPARTATE AMINOTRANSFERASE INCREASED 5 0.0001
938 OEDEMA 5 0.0001
939 CHOLELITHIASIS 3 0.0001
940 DYSPEPSIA 9 0.0001
941 DEPENDENCE 5 0.0001
942 BLOOD PRESSURE DECREASED 6 0.0001
943 FUNGAL INFECTION 3 0.0001
944 ARTHROPATHY 5 0.0001
945 DELIRIUM 3 0.0001
946 ABDOMINAL PAIN 20 0.0001
947 LYMPHADENOPATHY 3 0.0001
948 PLATELET COUNT DECREASED 9 0.0001
949 CEREBRAL HAEMORRHAGE 3 0.0001
950 PAIN 51 0.0001
951 DRUG EFFECT INCOMPLETE 3 0.0001
952 HYPERGLYCAEMIA 3 0.0001
953 INTESTINAL OBSTRUCTION 3 0.0001
954 MUSCULOSKELETAL PAIN 4 0.0001
955 EYE IRRITATION 4 0.0001
956 ANGIOEDEMA 3 0.0001
957 HOT FLUSH 5 0.0001
958 BLOOD PRESSURE INCREASED 10 0.0001
959 INTENTIONAL OVERDOSE 4 0.0001
960 DRY EYE 3 0.0001
961 GASTROINTESTINAL HAEMORRHAGE 5 0.0001
962 EMOTIONAL DISTRESS 7 0.0001
963 ARTHRALGIA 24 0.0001
964 PARAESTHESIA 9 0.0001
965 DERMATITIS ATOPIC 3 0.0001
966 WHITE BLOOD CELL COUNT DECREASED 6 0.0001
967 PAIN IN EXTREMITY 16 0.0001
968 CHEST PAIN 10 0.0001
969 NECK PAIN 3 0.0001
970 CEREBROVASCULAR ACCIDENT 9 0.0001
971 CHRONIC KIDNEY DISEASE 4 0.0001
972 DIABETES MELLITUS 4 0.0001
973 DRY SKIN 7 0.0001
974 INJECTION SITE HAEMORRHAGE 4 0.0001
975 THROMBOSIS 4 0.0000
976 JOINT SWELLING 6 0.0000
977 DRY MOUTH 4 0.0000
978 ACCIDENTAL EXPOSURE TO PRODUCT 5 0.0000
979 SKIN EXFOLIATION 4 0.0000
980 PRURITUS 18 0.0000
981 ACUTE KIDNEY INJURY 7 0.0000
982 NEOPLASM MALIGNANT 3 0.0000
983 DEVICE MALFUNCTION 3 0.0000
984 ARTHRITIS 3 0.0000
985 PALPITATIONS 4 0.0000
986 HYPOAESTHESIA 5 0.0000
987 NEUROPATHY PERIPHERAL 3 0.0000
988 BACK PAIN 6 0.0000
989 MYALGIA 4 0.0000
990 MYOCARDIAL INFARCTION 3 0.0000
991 BLOOD GLUCOSE INCREASED 3 0.0000
992 INJECTION SITE PAIN 3 0.0000